<DOC>
	<DOC>NCT00461110</DOC>
	<brief_summary>The purpose of this study is to determine the maximum tolerated dose and assess the safety and tolerability of escalating doses of BMS-663513 when given in combination with either radiotherapy alone or radiotherapy plus paclitaxel and carboplatin.</brief_summary>
	<brief_title>A Study of BMS-663513 in Combination With Chemoradiation in Subjects With Non Small Cell Lung Carcinoma (NSCLC)</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>NSCLC who are eligible to receive a 6 week course of RT Part 1 not candidates for definitive RT Part 2 candidates for definitive RT Severe COPD, pulmonary infection or interstitial pneumonitis Recent cellulitis Autoimmune disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>